Global E-Clinical Trial Technologies Industry

• Publication date: July 2012
• Report size: 532 pages

This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 80 companies including many key and niche players such as Aris Global, BioClinica, Cli...

This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 80 companies including many key and niche players such as Aris Global, BioClinica, Clinipace Worldwide, Cmed Technology Ltd., DATATRAK International, Inc., DZS Software Solutions, Inc., eResearchTechnology, Inc., Medidata Solutions, Inc., Merge Healthcare, Inc., OmniComm Systems, Inc., Oracle Inc., Phase Forward, Inc., PAREXEL International Corporation, Perceptive Informatics, Inc., PharmaPros Corporation, Prelude Dynamics LLC, SAS Institute Inc., Target Health Inc., and Trianz Solutions. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Global Drug Discovery And Development Industry

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Select Systems/Technologies Used in E-Clinical Trials I-3


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
A Prelude II-1
Current & Future Analysis II-1
Key Statistics II-2
Table 1: Percentage Breakup of Global R&D Spending by Region:
2011 (includes corresponding Graph/Chart) II-2

Table 2: Percentage Breakup of Global R&D Spending by Sector
for: 2010 & 2011 (includes corresponding Graph/Chart) II-2

Table 3: Comparison of Clinical Trial Costs between India and
US by Trial Phase (includes corresponding Graph/Chart) II-2
Key Market Trends and Issues II-3
Pharma - In Search of New Tools to Counteract Increasing
Pressure on Pipelines II-3
Rising Costs Drive Clinical Trials Out of Traditional Markets II-3
China and India: The New Hot Spots for R&D Investment II-4
Challenges Trailing Globalization II-4
Enhanced Regulatory Acceptance Drives E-Clinical Trial Adoption II-5
Competitive Landscape II-5
Oracle Dominates the eClinical Trial Solutions Space II-5
Oracle’s Acquisition Spree Heats up Competition II-5
Table 4: Leading Players in the Global E-Clinical Software
Solutions Market (2011): Percentage Breakdown of Revenues
for Oracle/Phase Forward, Medidata, PAREXEL, eResearch
Technology, BioClinica, and Others (includes corresponding
Graph/Chart) II-6

2. TECHNOLOGICAL TRENDS II-7
Systems Integration Becomes Imperative II-7
Evolution of Integrated Technologies in E-Clinical Trial II-7
Benefits of Technology Integration - A Focus on ePRO and EDC
Integration II-7
The Need for Data Harmonization II-8
EDC Segment Witnesses Upward Trend II-8
EDC Usage Rises, and so have Related Issues II-8
ePRO Gaining Ground in Oncology Trials II-9
Advanced Solutions in CTMS II-9
Snapshot of Select Leading CTMS Solutions II-10
Open Source-Emerging Solutions in Clinical Trials Domain II-10
Select Open Source Technologies for Clinical Trials by
Application Area II-10
Benefits over Proprietary Technologies to Encourage Adoption II-11
EDC- The Most Attractive Application for Open Source II-11
Conversion to CDISC - An Emerging Application for Open Source
Solutions II-11
Mobile Technology - To Tackle Unaddressed Challenges II-11
The Evolutionary Move to eDevelopment II-12

3. E-CLINICAL TRIALS- A BROADER SPECTRUM II-13
Select Systems Used in E-Clinical Trials II-13
Clinical Trial Management System II-13
Electronic Data Capture Solutions II-14
EDC and Paper CRFs - A Comparison II-14
Interactive Voice Response Systems II-15
Electronic Patient Reported Outcome II-15
Benefits Offered by E-Clinical Trials II-15
Transparency II-16
Dynamic Program Management II-16
Effective Trial Drug Supply II-16
Effective Study Randomization II-16
Enhanced Collaboration II-16
Dynamic Site Management II-17
Less Frequent Investigational Site Visits II-17
Faster Go- No Go Decisions II-17
Better Planning II-17
Regulatory Compliance II-17
CDISC Standards II-17
Clinical Trials- In a Nutshell II-18
Summarization of Clinical Trial Phases & Time Line for Drug
Development II-18

4. PRODUCT/SERVICE INTRODUCTIONS II-19
Synteract Launches SynCapture™ EDC System in Version 1.5 II-19
BioClinica Introduces BioClinica OnPoint Clinical Trial
Management System II-19
Perceptive Informatics Unveils DataLabs® Electronic Data Capture II-19
CRF Health Launches TrialMax Synapse™ Open ePRO Integration
Interface II-20
eClinical Solutions Rolls Out eGrex Clinical Data Repository
Solution in Version 4.0 II-20
Aris Global Launches agCapture II-20
DZS Software Introduces ClinPlus® Data Management 3.3 II-21
KIKA Introduces Veracity™ 3.10 II-21
ERT Introduces Novel ePRO Solutions II-22
DATATRAK Introduces New DATATRAK eClinical™ Solution II-22
BioClinica Introduces Trident IWR II-22
Trianz Introduces Advance Version of Acceliant™ eClinical Suite II-22
PharmaPros Introduces New eClinical OnDemand™ Solution II-23
BioClinica™ Introduces BioClinica Optimizer II-23
Medidata Solutions Launches Medidata Balance™ II-23
Medidata Solutions Launches Rave Targeted SDV II-24
Merge Healthcare Introduces CIMS Imaging Solution for Clinical
Trials II-24
Phase Forward Upgrades Phase Forward™ II-24
Phase Forward Launches Empirica™ Study II-25
SAS Introduces JMP Clinical software II-25
MedNet Solutions Rolls Out iMedNet™ II-25
Cmed Technology Launches Timaeus HotSpot and Timaeus 5 II-26
Parexel Unveils Web Based Technology Platform II-26
Aris Global Unveils Total Clinical 2.0 II-26
OmniComm Launches TrialOne™ II-27
DATATRAK International Unveils eClinical™ 9.0 Software II-27
DATATRAK International Unveils DATATRAK ONE™ II-27
Medidata Solutions Launches Rave Safety Gateway II-28
Perceptive Informatics Unveils E-Clinical Suite II-28
Medidata Solutions Rolls Out Rave Monitor II-28
Target Health Unveils Target e*CRF Version 1.7 II-29

5. RECENT INDUSTRY ACTIVITY II-30
Greenphire Enters into Strategic Partnership with Merge
Healthcare II-30
PharmaPros Inks Partnership Agreement with OmniComm Systems II-30
DATATRAK International Inks Enterprise Agreement with
Specialty Biotech II-30
Medidata Solutions Acquires Clinical Force II-31
BioClinica Enters into Partnership with Kaizen II-31
Cmed Group Establishes Cmed Technology II-31
Perceptive Informatics Incorporates TIBCO Active Matrix
Business Works™ Software and TIBCO Enterprise Message
Service™ II-31
Medidata Collaborates with Aris Global to Provide Integrated
Solution II-32
Merge Healthcare Deploys etrials eDiary 5.0 II-32
Health Decisions and OmniComm Ink Agreement for TrialMaster
EDC Solution II-32
Perceptive Integrates Technology of IBM in E-Clinical Platform II-32
Mediadata Collaborates with Spaulding Clinical II-33
OmniComm Combines Microsoft HealthVault with TrialMaster II-33
Perceptive Combines WebFOCUS Technology with E-Clinical Solution II-33
Phase Forward Inks Agreement with Integrium II-34
Aris Global Chooses invivodata as Preferred Partner for ePRO
Solutions II-34
Romark Laboratories Selects ClinPlus® Coding systems and
ClinPlus® Data Management II-34
Trianz Solutions and REGISTRAT-MAPI Release Acceliant V6.1 II-34
GlaxoSmithKline Signs Agreement with BioClinica® II-35
KeyPoint CRO Signs Agreement with DATATRAK International II-35
Progenics Pharmaceuticals Selects Medidata Platforms II-35
Orion Renews Contract with Medidata Solutions II-35
Sundise Chooses Medidata Rave® for Clinical Trial in the US
Market II-36
Carestream Health Collaborates with KIKA™ Clinical Solutions
for Clinical Trails II-36
BioClinica Takes Over TranSenda International II-36
ERT Takes Over Research Services Division of CareFusion
Corporation II-37
Oracle Acquires Phase Forward II-37
Clinipace Takes Over Worldwide Clinical Research II-37
Phase Forward Takes Over Waban Software II-37
BioClinica Takes Over Tourtellotte Solutions II-38
Phase Forward Acquires Business Unit of Covance II-38
OmniComm Takes Over EDC Assets of Logos Technologies II-38
Phase Forward Takes Over Maaguzi II-39
OmniComm Systems Takes Over EDC Business of eResearch Technology II-39
Inclinix and DATATRAK International Enter into Strategic
Partnership II-39
Target Health Enters into Partnership with LifeOnKey II-40
Aris Global Collaborates with SAP for agClinical NW II-40
Impax Pharmaceuticals Selects TrialMaster EDC Solution of
OmniComm Systems II-40
Shire Extends Contract with Medidata II-41
Medidata Launches Clinical Trial Technology Partners Program II-41
Bristol-Myers Squibb Extends Contract with Medidata II-41
Roche Selects Medidata Rave® for Electronic Data Capture II-42
U-Systems Selects Medidata Rave® as EDC Standard II-42
Phase Forward Extends Contract with Everest Clinical Research
Services II-42
FUJIFILM Medical Systems Chooses Dataflow Manager™ of PharmaPros II-42
Terumo Collaborates with KIKA II-43

6. FOCUS ON SELECT PLAYERS II-44
Aris Global (US) II-44
BioClinica (US) II-44
Clinipace Worldwide (US) II-44
Cmed Technology Ltd (UK) II-45
DATATRAK International, Inc. (US) II-45
DZS Software Solutions, Inc. (US) II-45
eResearchTechnology, Inc. (US) II-45
Medidata Solutions, Inc. (US) II-46
Merge Healthcare, Inc. (US) II-46
OmniComm Systems, Inc. (US) II-46
Oracle Inc. (US) II-47
Phase Forward, Inc. (US) II-47
PAREXEL International Corporation (US) II-47
Perceptive Informatics, Inc. (US) II-48
PharmaPros Corporation (US) II-48
Prelude Dynamics LLC (US) II-48
SAS Institute Inc. (US) II-49
Target Health Inc. (US) II-49
Trianz Solutions (US) II-49

7. GLOBAL MARKET PERSPECTIVE II-50
Table 5: World Recent Past, Current & Future Analysis for
E-Clinical Trial Technologies by Geographic Region - US,
Canada, Japan, Europe, and Rest of World Markets Independently
Analyzed with Annual Revenue Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) II-50

Table 6: World Historic Review for E-Clinical Trial
Technologies by Geographic Region - US, Canada, Japan, Europe,
and Rest of World Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) II-51

Table 7: World 15-Year Perspective for E-Clinical Trial
Technologies by Geographic Region - Percentage Breakdown of
Dollar Revenues for US, Canada, Japan, Europe, and Rest of
World Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) II-52


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Product/Service Launches III-1
Strategic Corporate Developments III-11
Select Key Players III-22
B.Market Analytics III-29
Table 8: The US Recent Past, Current & Future Analysis for
E-Clinical Trial Technologies Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-29

Table 9: The US Historic Review for E-Clinical Trial
Technologies Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-30

2. CANADA III-31
Market Analysis III-31
Table 10: Canadian Recent Past, Current & Future Analysis
for E-Clinical Trial Technologies Analyzed with Annual
Revenue Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-31

Table 11: Canadian Historic Review for E-Clinical Trial
Technologies Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-32

3. JAPAN III-33
A.Market Analysis III-33
Current & Future Analysis III-33
B.Market Analytics III-34
Table 12: Japanese Recent Past, Current & Future Analysis
for E-Clinical Trial Technologies Analyzed with Annual
Revenue Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-34

Table 13: Japanese Historic Review for E-Clinical Trial
Technologies Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-35

4. EUROPE III-36
A.Market Analysis III-36
Current & Future Analysis III-36
Product/Service Launches III-36
Strategic Corporate Developments III-37
Cmed Technology Ltd - A Key European Player III-38
B.Market Analytics III-39
Table 14: European Recent Past, Current & Future Analysis
for E-Clinical Trial Technologies Analyzed with Annual
Revenue Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-39

Table 15: European Historic Review for E-Clinical Trial
Technologies Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-40

5. REST OF WORLD III-41
A.Market Analysis III-41
China- A Potential Market III-41
Chinese Pharma Companies Still Aloof to EDC Adoption III-41
Price Corrections - A Bare Necessity for Vendors to Succeed III-42
CTMS Adoption - Still Far Away III-42
Smaller Vendors Possess Better Prospects in Immediate Future III-42
Strategic Corporate Developments III-42
B.Market Analytics III-44
Table 16: Rest of World Recent Past, Current & Future
Analysis for E-Clinical Trial Technologies Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-44

Table 17: Rest of World Historic Review for E-Clinical Trial
Technologies Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-45


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 80 (including Divisions/Subsidiaries - 82)

The United States (56)
Canada (3)
Japan (2)
Europe (18)
- France (2)
- Germany (1)
- The United Kingdom (8)
- Italy (1)
- Rest of Europe (6)
Asia-Pacific (Excluding Japan) (2)
Africa (1)